Skip to main content
Premium Trial:

Request an Annual Quote

New York Approves Natera's CLIA Laboratory

NEW YORK (GenomeWeb News) – Natera today announced that New York has issued a permit for the company's CLIA laboratory, allowing Natera to offer its preconception and prenatal tests to expecting parents in the state.

The New York State Department of Health issued a clinical laboratory permit for the company's CLIA-certified laboratory in San Carlos, Calif. Approval includes Natera's Panorama non-invasive prenatal test for fetal aneuploidies, the firm said.

The test, launched earlier this year, uses a blood draw to detect trisomy 21, 18, and 13, as well as monosomy X, triploidy, and sex chromosome aneuploidies. It employs Natera's algorithm called Next Generation Aneuploidy Testing Using SNPs to analyze cell-free DNA from both the mother and the fetus.

Natera last week announced an agreement with DiagCor to bring Panorama to Hong Kong. It has deals with Quest Diagnostics, Bio-Reference Laboratories, and Arup Laboratories to offer its test in the US.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.